Nan Fung Life Sciences (NFLS), part of the Nan Fung Group, is a $2bn global investment platform focusing on life sciences. Nan Fung Life Sciences has significant presence in both US and Greater China through direct investments via Pivotal bioVenture Partners funds and fund investments covering therapeutics, medical devices, diagnostics & research tools, and Healthcare…
Read MoreVariant Bio is a private biotech company that offers a genomic platform for drug development companies to further their research and discover therapeutic methods that can improve patients’ lifespan. LifeSci Search partnered with Variant Bio as they sought to bring aboard a few new team members from multifaceted backgrounds to maintain their growing network of…
Read MoreAlkahest is a clinical stage biopharmaceutical company dedicated to discovering and developing treatments for neurodegenerative and age-related diseases with transformative therapies targeting the aging plasma proteome. They were acquired by Grifols, a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions in early 2021 and continues to operate…
Read MoreAtonarp’s optical, mass spectrometer, and advanced informatic/software offerings provide the ability to “digitize” diagnostic testing. By eliminating the need for existing reagents and chemistries their technology allows for a quick diagnostic for a variety of acute and chronic diseases, amongst other standard diagnostic panels. Led by seasoned investors and raised over $100MM to date, their…
Read More